Proteoglycan 4 anticorps (N-Term)
Aperçu rapide pour Proteoglycan 4 anticorps (N-Term) (ABIN5518064)
Antigène
Voir toutes Proteoglycan 4 (PRG4) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- KIKSSKNSAA NRELQKKLKV KDNKKNRTKK KPTPKPPVVD EAGSGLDNGD
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human PRG4
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 23 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Proteoglycan 4 (PRG4)
-
Autre désignation
- PRG4
-
Sujet
-
The protein encoded by this gene is a large proteoglycan that is synthesized by chondrocytes located at the surface of articular cartilage and by some synovial lining cells. This protein contains both chondroitin sulfate and keratan sulfate glycosaminoglycans. It functions as a boundary lubricant at the cartilage surface and contributes to the elastic absorption and energy dissipation of synovial fluid. Mutations in this gene result in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Alternative splicing results in multiple transcript variants.
Alias Symbols: MSF, SZP, CACP, HAPO, JCAP
Protein Size: 853 -
ID gène
- 10216
-
NCBI Accession
- NP_001121180
-
UniProt
- J3KP74
Antigène
-